Effect of extract from laquer tree (Rhus verniciflua Stokes) on DNCB-induced atopic dermatitis in NC/Nga mouse

Food Science and Biotechnology

Volumn 21, Issue 5, 2012, Pages 1321-1327

  Yang, Jung Eun ^a   Lee, Jung Min ^a   Shin, Heon Sub ^a   Park, Sang Yong ^a   Lee, Don Gil ^a   Mavlonov, Gafurjon T ^a   Lee, Woo Cheol ^b   Cho, Somi Kim ^c   Yi, Tae Hoo ^a  

^a Kyung Hee University   (South Korea)

^b Eulji University   (South Korea)

^c Jeju National University   (South Korea)

Author keywords

atopic dermatitis; immunoglobulin E (IgE); interferon ; interleukin 4; Rhus verniciflua Stokes (Anacardiaceae)

Indexed keywords

ANACARDIACEAE; ANTI-INFLAMMATION; ANTI-INFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; DEXAMETHASONES; IMMUNOGLOBULIN E; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MAST CELLS; ORAL ADMINISTRATION; ORIENTAL MEDICINES;

FATTY ACIDS; FORESTRY; NITRIC OXIDE; PHENOLS;

MAMMALS;

ANIMALS; DISEASES; FATTY ACIDS; FORESTRY; MAMMALS; MEDICINE; NITROGEN OXIDES; PLANTS;

ANACARDIACEAE; HEDERA; MUS; TOXICODENDRON VERNICIFLUUM;

EID: 84868310650     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-012-0174-2     Document Type: Article

References (27)

1. Novak N. New insights into the mechanism and management of allergic diseases: Aopic dermatitis. Allergy 64: 265-275 (2009).
2. Pate MB, Smith JK, Chi DS, Krishnaswamy G. Regulation and dysregulation of immunoglobulin E: A molecular and clinical perspective. Clin. Mol. Allergy 8: 3-15 (2010).
3. Reinhold U, Pawelec G, Wehrmann W, Herold M, Wernet P, Kreysel HW. Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-γ and neopterin in patients with severe atopic dermatitis. Int. Arch. Aller. A. Imm. 87: 120-126 (1998).
4. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol. 136: 949-954 (1986).
5. Angelini F, Di Matteo G, Balestrero S, Brunetti E, Mancino G, Rossi P, Galle E. Nuclear factor-κB activity is increased in peripheral blood mononuclear cells of children affected by atopic and nonatopic eczema. Int. J. Immunopath. Ph. 20: 59-67 (2007).
6. Barnes PJ, Karin M. Nuclear factor-κB: Apivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336: 1066-1071 (1997).
7. Nakamura H, Aoki M, Tamai K, Oishi M, Ogihara T, Kaneda Y, Morishita R. Prevention and regression of atopic dermatitis by ointment containing NF-κB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther. 9: 1221-1229 (2002).
8. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107: 135-142 (2001).
9. Tanaka A, Muto S, Jung K, Itai A, Matsuda H. Topical application with a new NF-κB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J. Invest. Dermatol. 127: 855-863 (2007).
10. Duan W, Wong WS. Targeting mitogen-activated protein kinases for asthma. Curr. Drug Targets 7: 691-698 (2006).
11. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YH, Kim SH. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res. 31: 1303-1311 (2008).
12. Jung CH, Kim JH, Hong MH, Seog HM, Oh SH, Lee PJ, Kim GJ, Kim HM, Um JY, Ko SG. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-κB and JNK pathway in lipopolysaccharide-induced RAW 264. 7 macrophages. J. Ethnopharmacol. 110: 490-497 (2007).
13. Hong MH, Kim JH, Lee SY, Go HY, Kim JH, Shin YC, Kim SH, Ko SG. Early antiallergic inflammatory effects of Rhus verniciflua Stokes on human mast cells. Phytother. Res. 24: 288-294 (2010).
14. Elsohly MA, Turner CE. GLC analysis of poison ivy and poison oak urushiol components in vegetable oil preparations. J. Pharm. Sci. 69: 587-589 (1980).
15. Draper WM, Wijekoon D, McKinney M, Behniwal P, Perera SK, Flessel CP. Atmospheric pressure ionization LC-MS-MS determination of urushiol congeners. J. Agr. Food Chem. 50: 1852-1858 (2002).
16. Inagaki N, Igeta K, Kim JF, Nagao M, Shiraishi N, Nakamura N, Nagai H. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur. J. Pharmacol. 448: 175-183 (2002).
17. Inagaki N, Igeta K, Shiraishi N, Kim JF, Nagao M, Nakamura N, Nagai H. Evaluation and characterization of mouse scratching behavior by a new apparatus, MicroAct. Skin Pharmacol. Appl. 16: 165-175 (2003).
18. Lee SH, Kim KS, Choi WC, Yoon SW. Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua Stokes extract: A case study. Explore -NY 5: 242-244 (2009).
19. Qi XF, Kim DH, Yoon YS, Li JH, Song SB, Jin D, Huang XZ, Teng YC, Lee KJ. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-κB in HaCaT keratinocytes. Mol. Immunol. 46: 1925-1934 (2009).
20. Marquardt DL, Walker LL. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity. J. Allergy Clin. Immun. 105: 500-505 (2000).
21. Kraft S, Novak N, Katoh N, Bieber T, Rupec RA. Aggregation of the high-affinity IgE receptor Fce{open}RI on human monocytes and dendritic cells induces NF-κB activation. J. Invest. Dermatol. 118: 830-837 (2002).
22. Lee JC, Lim KT, Jang YS. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochim. Biophys. Acta 1570: 181-191 (2002).
23. Trenam CW, Blake DR, Morris CJ. Skin inflammation: Reactive oxygen species and the role of iron. J. Invest. Dermatol. 99: 675-682 (1992).
24. Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, Park DS. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int. Immunopharmacol. 9: 268-276 (2009).
25. Horsmanheimo L, Harvima IT, Jarvikallio A, Harvima RJ, Naukkarinen A, Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Brit. J. Dermatol. 131: 348-353 (1994).
26. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis. Arch. Dermatol. Res. 293: 350-355 (2001).
27. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. P. Natl. Acad. Sci. USA 91: 3652-3656 (1994).